Cargando…
Profiling structured product labeling with NDF-RT and RxNorm
BACKGROUND: Structured Product Labeling (SPL) is a document markup standard approved by Health Level Seven (HL7) and adopted by United States Food and Drug Administration (FDA) as a mechanism for exchanging drug product information. The SPL drug labels contain rich information about FDA approved cli...
Autores principales: | Zhu, Qian, Jiang, Guoqian, Chute, Christopher G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3570438/ https://www.ncbi.nlm.nih.gov/pubmed/23256517 http://dx.doi.org/10.1186/2041-1480-3-16 |
Ejemplares similares
-
Use of RxNorm and NDF-RT to normalize and characterize participant-reported medications in an i2b2-based research repository
por: Blach, Colette, et al.
Publicado: (2014) -
Normalizing Dietary Supplement Product Names Using the RxNorm Model
por: Vasilakes, Jake, et al.
Publicado: (2019) -
Comparing the representation of medicinal products in RxNorm and SNOMED CT – Consequences on interoperability
por: Noel Nikiema, Jean, et al.
Publicado: (2019) -
Building a drug ontology based on RxNorm and other sources
por: Hanna, Josh, et al.
Publicado: (2013) -
Recent Developments in Clinical Terminologies — SNOMED CT, LOINC, and RxNorm
por: Bodenreider, Oliver, et al.
Publicado: (2018)